Canaria Combination Tablets, manufactured by Mitsubishi Tanabe Pharma, contain Teneligliptin hydrobromide hydrate and Canagliflozin hydrate, YJ code 3969106F1028, 1 tablet. These tablets are generally prescribed for the treatment of type 2 diabetes.
Canaria Combination Tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).